Related Experiment Videos
Iscador Qu for chronic hepatitis C: an exploratory study
K J Tusenius1, J M Spoek, C W Kramers
1Berg en Bosch Medical Centre, Bilthoven, the Netherlands. tusenius@worldonline.nl
Complementary Therapies in Medicine
|March 27, 2001
Abstract:
Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.